Houston Medical Imaging

What Houston Medical Imaging does

Houston Medical Imaging (HMI) is a network of 13-14 outpatient diagnostic imaging centers serving the Houston metropolitan area and Edinburg, Texas. The company provides a full range of imaging modalities including MRI (1.5T and 3T), CT, PET/CT, ultrasound, digital X-ray, 3D mammography, breast MRI, prostate MRI, nuclear medicine, fluoroscopy, DEXA bone density, and cardiac imaging. Patients are acquired primarily through referring physician orders (faxed to the centralized scheduling line) and through direct scheduling, walk-in X-ray, and self-referred screening pathways such as mammography and the Enhanced Prostate Screening program. The referring physician base is supported through the Connect provider portal for real-time access to patient results and images, while patients access records through the Texas Patient Portal.

HMI differentiates its clinical offering through multiple AI-augmented diagnostic tools deployed across service lines, including the Enhanced Breast Cancer Detection (EBCD) program using DeepHealth's computer vision on 3D mammograms, the FDA-cleared Enhanced Prostate Screening (EPS) for prostate MRI interpretation, NeuroQuant/LesionQuant/Icobrain for volumetric brain analysis, AI-driven plaque quantification on coronary CT angiography, and AI-assisted thyroid ultrasound. The facilities are staffed by board-certified, subspecialty-trained radiologists including fellowship-trained neuroradiologists and nuclear medicine physicians. Beyond patient imaging, HMI maintains a research operations function that has supported over 350 clinical trials with pharmaceutical sponsors including Merck, Pfizer, Eli Lilly, and AstraZeneca, utilizing imaging modalities as endpoints for liver disease, Alzheimer's, cancer, obesity, and orthopedic studies.

HMI operates as a division of RadNet, the nation's largest outpatient imaging operator with 35+ years of experience, and benefits from RadNet's centralized RIS/PACS infrastructure and national brand recognition. Revenue is generated primarily through fee-for-service diagnostic imaging billed to commercial insurance, Medicare/Medicaid, and self-pay patients, supplemented by self-pay AI screening products (e.g., $275 EPS) and B2B clinical research imaging services. The company accepts most major insurance plans and offers Good Faith Estimates for uninsured patients, positioning itself as a lower-cost alternative to hospital outpatient imaging departments.

Name

Houston Medical Imaging

Legal name

Houston Medical Imaging

Website

https://houstonimaging.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Houston Medical Imaging operates 13-14 outpatient diagnostic imaging centers across the Houston metro and Edinburg, Texas, offering MRI, CT, 3D mammography, and AI-augmented screening (breast, prostate, neuro, cardiac) to patients, referring physicians, and pharmaceutical clinical trial sponsors.

Ownership category

akta.pro rank

Product category

Outpatient Diagnostic Imaging Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA)

akta.pro secondary industries

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Women’s Imaging & Breast Health Centers (HLAFAJAJ)

Keywords

• Diagnostic imaging services
• Outpatient radiology
• MRI and CT scans
• 3D mammography screening
• AI-powered radiology

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices14 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Imaging Services: Houston Medical Imaging generates revenue through providing diagnostic imaging services (MRI, CT, PET/CT, Ultrasound, X-Ray, Mammography, DEXA, Nuclear Medicine, etc.) billed to insurance providers, Medicare/Medicaid, and self-pay patients. Services include both routine screenings and diagnostic examinations ordered by physicians or self-referred for certain screening services.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Houston Medical Imaging is a network of 13-14 outpatient imaging centers across the Houston metro area that provides diagnostic radiology services including MRI, CT, PET/CT, Ultrasound, Nuclear Medicine, X-Ray, Fluoroscopy, DEXA, 3D Mammography, Breast MRI, Prostate MRI, and Cardiac Imaging. The network leverages AI-powered diagnostic tools (EBCD, EPS, NeuroQuant, LesionQuant, Icobrain, AI Plaque Analysis) and is staffed by board-certified, subspecialty-trained radiologists. It operates as a division of RadNet and has supported over 350 clinical research trials.

Product overview

Houston Medical Imaging (HMI) is a network of 14 outpatient imaging centers across the Houston metro area offering comprehensive diagnostic radiology services. The core offering consists of multiple imaging modalities (MRI/MRA, CT, Ultrasound, PET/CT, Nuclear Medicine, X-Ray, Fluoroscopy, DEXA) delivered through state-of-the-art facilities staffed by subspecialty-trained radiologists. The portfolio includes specialized services such as 3D Mammography, Breast MRI, Prostate MRI, Neuroradiology, and Cardiac Imaging. HMI differentiates through AI-powered diagnostic tools including Enhanced Breast Cancer Detection (EBCD) using DeepHealth AI, Enhanced Prostate Screening (EPS), NeuroQuant, LesionQuant, Icobrain for neuroimaging, and CCTA with AI Plaque Analysis. The network operates dedicated Women's Breast Centers and provides patient/provider digital portals for results access. HMI is a division of RadNet and has supported over 350 clinical research trials.

Differentiator

Problem solved

Functional benefit

Brands

• Enhanced Breast Cancer Detection (EBCD): A breakthrough early breast cancer detection program using artificial intelligence to help radiologists detect subtle lesions combined with exceptionally high-quality mammography systems.
• Enhanced Prostate Screening (EPS)

Products and services

• MRI/MRA Advanced magnetic resonance imaging using powerful magnetic fields and radio waves to create detailed images of organs, muscles, bones, and blood vessels (MRA). Available in 1.5T and 3T field strengths.
• Ultrasound Safe, painless diagnostic imaging using high-frequency sound waves to create real-time images of organs, tissues, and blood flow without radiation exposure.
• PET/CT Combined positron emission tomography and CT imaging that shows both anatomical structure and cellular function to detect early signs of cancer, heart disease, and brain conditions.
• Nuclear Medicine Specialized diagnostic imaging using radioactive radiotracers to evaluate organ and tissue function at the cellular level, particularly for oncology, cardiology, and organ health assessment.
• Fluoroscopy Real-time X-ray movie imaging using contrast material to visualize moving organs and guide procedures such as catheter placement, myelograms, and lumbar punctures.
• DEXA/Bone Density Gold-standard bone density scanning using minimal X-ray radiation to measure bone mineral content and assess risk for osteoporosis and fractures.
• X-Ray Digital X-ray imaging using low-level radiation to quickly capture images of bones, lungs, and organs for diagnosis of fractures, infections, and other conditions. Available on walk-in basis.
• CT Scan Advanced cross-sectional X-ray imaging producing detailed slices of the body to evaluate tumors, infections, bone injuries, and vascular conditions. Includes specialized cardiac CT angiography.
• 3D Mammography Advanced tomosynthesis X-ray technology capturing multiple images from different angles to create layered breast tissue views, improving cancer detection by 20-65% over traditional 2D mammography.
• Breast MRI Advanced magnetic resonance imaging of breast tissue using magnets and computer technology without X-ray radiation, typically used alongside mammography for high-risk screening and cancer evaluation.
• Prostate MRI Specialized MRI imaging of the prostate gland using magnetic fields and radio waves without radiation exposure, used for early cancer detection, staging, and biopsy guidance.
• Low-Dose CT Lung Cancer Screening Annual screening CT scan using minimal radiation to detect lung cancer early in high-risk individuals (ages 50-80, 20+ pack-year history). Procedure takes less than 10 minutes with no contrast or needles required.
• Arthrogram Special imaging procedure using fluoroscopy-guided contrast dye injection into joints combined with MRI, CT, or X-ray to diagnose tears in ligaments, tendons, cartilage, and evaluate joint replacements.
• Cardiac Imaging Comprehensive cardiac diagnostic imaging including CT Coronary Calcified Plaque Scoring, Coronary CTA (CCTA), Transthoracic Echocardiogram (TTE), CCTA with FFR-CT, and CCTA with AI Plaque Analysis.
• High-Field Open MRI Open MRI design providing comfort for claustrophobic, larger-bodied, or pediatric patients while delivering image quality comparable to conventional closed-bore MRI systems.
• Neuroradiology Imaging Fellowship-trained neuroradiology services providing brain and spine MRI, CT, PET imaging, and AI-powered analysis (NeuroQuant, LesionQuant, Icobrain) for neurological conditions including Alzheimer's, cancer, seizures, and vascular disorders.
• Enhanced Breast Cancer Detection (EBCD) AI-powered breast cancer screening program using DeepHealth technology to assist radiologists in detecting subtle lesions on mammograms. Includes 3D mammogram, AI-assisted detection, and second radiologist review for suspicious findings.
• Enhanced Prostate Screening (EPS) AI-powered prostate cancer screening for men age 45+ using DeepHealth FDA-cleared prostate MRI solution. Non-invasive, no IV contrast, 10-15 minute exam with minimal preparation required. Not covered by insurance, $275 self-pay.
• LiverMultiScan Non-invasive MRI scan by Perspectum assessing liver disease using quantitative metrics of liver fat content, iron concentration, and disease activity without contrast agents.
• Women's Breast Center Specialized women's imaging center offering screening and diagnostic 3D mammography, ultrasound-guided biopsy, stereotactic biopsy, and DEXA scans with fellowship-trained breast radiologists.
• CCTA with AI Plaque Analysis Coronary CT Angiography enhanced with machine learning AI software to quantify and characterize coronary artery plaque from standard CCTA images.
• CCTA with FFR-CT Coronary CT Angiography combined with fractional flow reserve computational analysis to evaluate the severity of coronary artery disease non-invasively.
• Thyroid Ultrasound with AI Thyroid ultrasound program combining high-resolution imaging with AI-supported technology to detect nodules, measure changes, and evaluate risk features for malignancy.

Quantifiable outcome

• Breast cancer detected at stage 1 has 99% five-year relative survival rate
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

• RadNetflagshipStrategic or Co-development PartnerHouston Medical Imaging is a division of the RadNet family of imaging centers, the nation's leader in outpatient imaging services. RadNet provides cutting-edge technology, world-class expertise, and patient-centered management across its network. HMI benefits from RadNet's 35+ years of experience, RIS/PACS solutions, and national brand recognition.
• MerckcoreStrategic or Co-development PartnerHouston Medical Imaging has partnered with Merck in clinical research trials supporting liver disease, Alzheimer's, cancer, obesity, and orthopedic research.
• PfizercoreStrategic or Co-development PartnerHouston Medical Imaging has partnered with Pfizer in clinical research trials supporting liver disease, Alzheimer's, cancer, obesity, and orthopedic research.
• Eli LillycoreStrategic or Co-development PartnerHouston Medical Imaging has partnered with Eli Lilly in clinical research trials supporting liver disease, Alzheimer's, cancer, obesity, and orthopedic research.
• AstraZenecacoreStrategic or Co-development PartnerHouston Medical Imaging has partnered with AstraZeneca in clinical research trials supporting liver disease, Alzheimer's, cancer, obesity, and orthopedic research.
• PerspectumcoreTechnology or IntegrationHouston Medical Imaging was an early leader in NASH and NAFLD research trials, partnering with Perspectum for LiverMultiScan MRI technology that non-invasively assesses liver disease activity, fat content, and iron concentration.
• Summit Medical ResearchminorStrategic or Co-development PartnerPartner in liver disease research trials, specifically NASH and NAFLD research.
• DeepHealthcoreTechnology or IntegrationDeepHealth provides FDA-cleared AI-powered technology for Enhanced Breast Cancer Detection (EBCD) and Enhanced Prostate Screening (EPS) programs. The AI optimizes breast cancer screening and prostate cancer detection.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• RadNet: Parent company and the nation's largest outpatient imaging platform with hundreds of centers; HMI is one of its divisions, and the two share the same RIS/PACS infrastructure and AI vendor relationships, making RadNet the closest direct comparability benchmark.

Direct peers

• U.S. Radiology Specialists: Private-equity-backed outpatient imaging platform with subspecialty radiology groups across multiple states; offers MRI, CT, PET/CT and women's imaging with a comparable hub-and-clinic operating model.
• RAYUS Radiology: National outpatient imaging network operating more than 140 centers across the U.S., offering MRI, CT, PET/CT, mammography, and interventional services with subspecialty radiologists — a direct operating peer in scale and service mix.
• Touchstone Medical Imaging: Outpatient imaging center operator with multiple regional locations offering MRI, CT, ultrasound, mammography, and X-ray; comparable mid-sized multi-modality ambulatory imaging model.
• SimonMed Imaging: One of the largest privately held outpatient imaging networks in the U.S., offering MRI, CT, PET/CT, mammography, and AI-augmented reads across multiple states with a similar subspecialist-led, physician-owned model to HMI.
• Akumin: Multi-state outpatient imaging operator providing MRI, CT, PET/CT, ultrasound, and X-ray services to referring physicians and patients; competes in the same ambulatory diagnostic imaging category with comparable modality breadth and payer mix.
• Zwanger-Pesiri Radiology: Large New York-based outpatient radiology group operating more than 60 offices with MRI, CT, PET/CT, mammography, and AI-augmented reads; closely comparable in modality breadth, AI adoption, and physician-owned ambulatory positioning.

Regional players

• Envision Radiology: Multi-state outpatient imaging group offering MRI, CT, mammography, and AI-supported screening programs to referring physicians and self-pay screening patients; relevant comparator for HMI's AI screening go-to-market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/houstonmedimage
• Facebookfacebook.com/HoustonMedImaging
• LinkedInlinkedin.com/company/houstonmedimaging

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Houston Medical Imaging